A comparison of Symbicort single inhaler therapy (Symbicort 200 Turbohaler 1 inhalation b.i.d. plus as needed) and conventional best practice for the treatment of persistent asthma in adolescents and adults-a 26-week, randomised, open-label, parallel group, multicentre study,
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms SOLO
- Sponsors AstraZeneca
- 13 Oct 2009 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
- 11 Jan 2008 Status changed from in progress to completed.
- 22 Dec 2005 New trial record.